# Biotech Daily Digest â€” 2025-11-11

**60 items from 4 sources**

## Summary by Source

- Endpoints News: 9 items
- Fierce Biotech: 10 items
- MHRA â€“ News: 2 items
- arXiv q-bio: 39 items


## Endpoints News

- **[Fabric buys UCM Digital Health in 5th acquisition in 3 years](https://endpoints.news/fabric-buys-ucm-digital-health-in-5th-acquisition-in-3-years/)**  
  _Tue, 11 Nov 2025 14:00:44 +0000_  
  Fabric, the New York-based health IT startup that provides software to help doctors conduct virtual appointments and automate the administrative work around them, like scheduling and taking stock of symptoms, has bought UCM Digital Health ...

- **[EnGene posts more pivotal data for bladder cancer gene therapy, plans 2026 filing](https://endpoints.news/engene-posts-more-pivotal-data-for-bladder-cancer-gene-therapy-plans-2026-filing/)**  
  _Tue, 11 Nov 2025 12:30:20 +0000_  
  EnGene has posted another tranche of encouraging bladder cancer treatment data from a pivotal trial, teeing up a BLA filing in the back half of next year.

 The company said that the gene therapy, called ...

- **[Neurocrine reports Phase 2 fail for depression drug it licensed from Takeda](https://endpoints.news/neurocrine-reports-phase-2-fail-for-depression-drug-it-licensed-from-takeda/)**  
  _Tue, 11 Nov 2025 11:40:18 +0000_  
  Neurocrine Biosciences said that a candidate for major depressive disorder that it got from Takeda did not succeed in a mid-stage trial.

 The oral drug, codenamed NBI-1070770, did not meet the primary endpoint. This used ...

- **[Jury gives Novo Nordisk a win in decade-long hemophilia fraud case](https://endpoints.news/jury-gives-novo-nordisk-a-win-in-decade-long-hemophilia-fraud-case/)**  
  _Mon, 10 Nov 2025 20:44:45 +0000_  
  Novo Nordisk did not defraud Medicare or Washington stateâ€™s Medicaid program through the promotion of its hemophilia drug, a federal jury has found.

 The verdict brings closure to a legal battle that has spanned more ...

- **[#AHA25: Novo Nordisk posts mixed mid-stage data on ATTR-CM drug](https://endpoints.news/aha25-novo-nordisk-posts-mixed-mid-stage-data-on-cardiomyopathy-drug-with-new-mechanism/)**  
  _Mon, 10 Nov 2025 20:00:37 +0000_  
  Three drugs are already approved for the progressive heart disease known as transthyretin-mediated amyloid cardiomyopathy (ATTR-CM). Novo Nordisk appears keen to enter the market anyway, despite mixed Phase 2 trial results.  ...

- **[Cogent soars on back of Phase 3 success in stromal tumors](https://endpoints.news/cogent-soars-on-back-of-phase-3-success-in-stromal-tumors/)**  
  _Mon, 10 Nov 2025 16:30:46 +0000_  
  Cogent Biosciencesâ€™ share price more than doubled on Monday after its drug candidate halved the risk of death or disease progression in a late-stage trial of a type of rare tumor that grows in the ...

- **[AnaptysBio reports Phase 2 fail in ulcerative colitis; Lyell's CAR-T licensing deal](https://endpoints.news/anaptysbio-reports-phase-2-fail-in-ulcerative-colitis-lyells-car-t-licensing-deal/)**  
  _Mon, 10 Nov 2025 16:14:00 +0000_  
  Plus, news about Tenaya, AtaiBeckley, Galecto, Damora, A2 Biotherapeutics, AstraZeneca and Evommune:

 ðŸ“‰ AnaptysBio's lead drug fails ulcerative colitis study: The company said the T cell depleter ...

- **[In string of deals, Lilly nabs ultra rare eye disease gene therapy and RNAi partner](https://endpoints.news/in-string-of-deals-lilly-nabs-ultra-rare-eye-disease-gene-therapy-and-rnai-partner/)**  
  _Mon, 10 Nov 2025 16:00:46 +0000_  
  Eli Lilly is expanding its genetic medicine repertoire through two new deals with biotech companies.

 It penned a deal on Monday with MeiraGTx for a gene therapy to treat a very ...

- **[#AHA25: CRISPR Therapeuticsâ€™ gene editing therapy halves cholesterol and triglycerides in early trial](https://endpoints.news/aha25-crispr-therapeutics-gene-editing-therapy-halves-cholesterol-and-triglycerides-in-early-trial/)**  
  _Mon, 10 Nov 2025 15:25:01 +0000_  
  One of CRISPR Therapeuticsâ€™ gene editing treatments cut levels of blood fats and cholesterol in an early-stage trial, according to data presented Saturday, raising the possibility of a once-and-done treatment for conditions that increase heart ...


## Fierce Biotech

- **[<a href="https://www.fiercebiotech.com/medtech/inbrain-neuroelectronics-pact-microsoft-leverage-ai-brain-computer-interface-tech" hreflang="en">Inbrain Neuroelectronics in pact with Microsoft to leverage AI for brain-computer interface tech</a>](https://www.fiercebiotech.com/medtech/inbrain-neuroelectronics-pact-microsoft-leverage-ai-brain-computer-interface-tech)**  
  _Nov 11, 2025 8:14am_  
  Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giantâ€™s Azure AI infrastructure to advance the Spanish companyâ€™s graphene-based brain-computer interface technology.

- **[<a href="https://www.fiercebiotech.com/biotech/neuphoria-reeling-phase-3-trial-fail-mulls-buyout-offer-investor" hreflang="en">Neuphoria, reeling from phase 3 trial fail, mulls buyout offer from investor</a>](https://www.fiercebiotech.com/biotech/neuphoria-reeling-phase-3-trial-fail-mulls-buyout-offer-investor)**  
  _Nov 11, 2025 8:15am_  
  As Neuphoria Therapeutics considers its options in the wake of the failure of its phase 3 social anxiety program, an investor has swooped in with one potential escape route.

- **[<a href="https://www.fiercebiotech.com/biotech/novo-nordisk-shares-mixed-data-behind-pivotal-heart-disease-push" hreflang="en">Novo Nordisk shares mixed data behind pivotal heart disease push</a>](https://www.fiercebiotech.com/biotech/novo-nordisk-shares-mixed-data-behind-pivotal-heart-disease-push)**  
  _Nov 11, 2025 8:32am_  
  Novo Nordisk has reported the mixed midphase results behind its push to enter a heart disease market served by Alnylam, BridgeBio and Pfizer.

- **[<a href="https://www.fiercebiotech.com/biotech/neurocrines-depression-drug-latest-asset-takeda-pact-flunk-phase-2-trial" hreflang="en">Neurocrine's depression drug is latest asset from Takeda pact to flunk a phase 2 trial</a>](https://www.fiercebiotech.com/biotech/neurocrines-depression-drug-latest-asset-takeda-pact-flunk-phase-2-trial)**  
  _Nov 11, 2025 5:12am_  
  Another of the psychiatry drugs Neurocrine licensed from Takeda has stumbled in the clinic.

- **[<a href="https://www.fiercebiotech.com/biotech/celecor-therapeutics-keeps-beat-ph-3-win-rapid-heart-attack-treatment" hreflang="en">CeleCor Therapeutics tees up FDA filing with phase 3 win for rapid heart attack treatment</a>](https://www.fiercebiotech.com/biotech/celecor-therapeutics-keeps-beat-ph-3-win-rapid-heart-attack-treatment)**  
  _Nov 10, 2025 5:50pm_  
  CeleCor presented the results of its pivotal CeleBrate phase 3 trial in a late-breaking session at the the American Heart Associationâ€™s annual scientific sessions.

- **[<a href="https://www.fiercebiotech.com/biotech/voyager-transition-bio-set-sail-neuro-research-trek-search-small-molecule-candidates" hreflang="en">Voyager, Transition Bio set sail on neuro research trek in search of small molecule candidates</a>](https://www.fiercebiotech.com/biotech/voyager-transition-bio-set-sail-neuro-research-trek-search-small-molecule-candidates)**  
  _Nov 10, 2025 5:18pm_  
  Voyager Therapeutics is shoving off on a new journey to discover and develop small molecules targeting protein bundles that contribute to neurodegenerative diseases. Voyager is paying travel partner Transition Bio a single-digit million-dollar upfront payment, with additional payments up to $500 million possible if ceâ€¦

- **[<a href="https://www.fiercebiotech.com/biotech/merck-pcsk9-pill-holds-significant-advantage-injectable-cholesterol-lowering-analysts" hreflang="en">Merck's PCSK9 pill holds 'significant advantage' with injectable-like cholesterol reductions: analysts</a>](https://www.fiercebiotech.com/biotech/merck-pcsk9-pill-holds-significant-advantage-injectable-cholesterol-lowering-analysts)**  
  _Nov 10, 2025 10:41am_  
  Merck & Co.â€™s PCSK9-targeted pill achieved low-density lipoprotein cholesterol (LDL-C) reductions similar to those observed with existing injectables.

- **[<a href="https://www.fiercebiotech.com/biotech/cogent-eyes-fda-submission-cancer-asset-after-clearing-another-phase-3-hurdle" hreflang="en">Cogent eyes FDA submission for cancer asset after clearing another phase 3 hurdle</a>](https://www.fiercebiotech.com/biotech/cogent-eyes-fda-submission-cancer-asset-after-clearing-another-phase-3-hurdle)**  
  _Nov 10, 2025 11:03am_  
  Cogent Biosciences has cleared another phase 3 hurdle for its lead asset, bezuclastinib, teeing up an FDA approval in submission for a gastrointestinal cancer in the first half of next year.

- **[<a href="https://www.fiercebiotech.com/biotech/anaptysbio-abandons-rosnilimab-ulcerative-colitis-after-phase-2-fail" hreflang="en">AnaptysBio abandons rosnilimab for ulcerative colitis after phase 2 fail</a>](https://www.fiercebiotech.com/biotech/anaptysbio-abandons-rosnilimab-ulcerative-colitis-after-phase-2-fail)**  
  _Nov 10, 2025 10:06am_  
  AnaptysBio has abandoned plans to develop rosnilimab for ulcerative colitis after the PD-1 agonist flunked a phase 2 study.

- **[<a href="https://www.fiercebiotech.com/biotech/lyell-signs-185m-deal-impressive-phase-1-stage-colorectal-cancer-car-t" hreflang="en">Lyell hands over $70M-plus in cash, equity for 'impressive' phase 1-stage colorectal cancer CAR-T</a>](https://www.fiercebiotech.com/biotech/lyell-signs-185m-deal-impressive-phase-1-stage-colorectal-cancer-car-t)**  
  _Nov 10, 2025 8:55am_  
  In a licensing deal unveiled Monday, Lyell Immunopharma is handing over $40 million in cash and almost 2 million of its shares to secure rights to a phase 1-stage CAR-T cell therapy for colorectal cancer.


## MHRA â€“ News

- **[Class 3 Medicines Recall: Sun Pharmaceutical Industries Limited, Atorvastatin 20mg and 80mg Film-coated Tablets, EL(25)A/48](https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-sun-pharmaceutical-industries-limited-atorvastatin-20mg-and-80mg-film-coated-tablets-el-25-a-slash-48)**  
  _2025-11-11T10:41:57Z_  
  Sun Pharma UK Limited are recalling the batches of tablets specified in the table as a precautionary measure due to failing dissolution test results reported during ongoing stability studies.

- **[MHRA-led study reveals major inconsistencies in global microbiome research](https://www.gov.uk/government/news/mhra-led-study-reveals-major-inconsistencies-in-global-microbiome-research)**  
  _2025-11-11T09:24:08Z_  
  International collaboration establishes new quality standards to improve reliability of gut health studies â€“ improving accuracy to provide better diagnosis and treatment.


## arXiv q-bio

- **[Rewiring Human Brain Networks via Lightweight Dynamic Connectivity Framework: An EEG-Based Stress Validation](https://arxiv.org/abs/2511.05505)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05505v1 Announce Type: new 
Abstract: In recent years, Electroencephalographic analysis has gained prominence in stress research when combined with AI and Machine Learning models for validation. In this study, a lightweight dynamic brain connectivity framework based on Time Varying Directed Transfer Functioâ€¦

- **[TEMPO: Temporal Multi-scale Autoregressive Generation of Protein Conformational Ensembles](https://arxiv.org/abs/2511.05510)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05510v1 Announce Type: new 
Abstract: Understanding the dynamic behavior of proteins is critical to elucidating their functional mechanisms, yet generating realistic, temporally coherent trajectories of protein ensembles remains a significant challenge. In this work, we introduce a novel hierarchical autoreâ€¦

- **[Molecular Dynamics Simulations of Membrane Selectivity of Star Peptides Across Different Bacterial and Mammalian Bilipids](https://arxiv.org/abs/2511.05513)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05513v1 Announce Type: new 
Abstract: Structurally nanoengineered antimicrobial peptide polymers (SNAPPs) are emerging as promising selective agents against bacterial membranes. In this study, we used all atom molecular dynamics simulation techniques to investigate the interaction of a promising cationic SNâ€¦

- **[sMRI-based Brain Age Estimation in MCI using Persistent Homology](https://arxiv.org/abs/2511.05520)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05520v1 Announce Type: new 
Abstract: In this study, we propose the use of persistent homology- specifically Betti curves for brain age prediction and for distinguishing between healthy and pathological aging. The proposed framework is applied to 100 structural MRI scans from the publicly available ADNI datâ€¦

- **[A Mechanistic Framework for in Silico Optimization of Neuroblastoma Chemo-Immunotherapy](https://arxiv.org/abs/2511.05527)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05527v1 Announce Type: new 
Abstract: A critical need exists for optimal therapeutic strategies for neuroblastoma, a prevalent and often fatal pediatric solid malignancy. To address the demand for quantitative models that can guide clinical decision-making, a novel mathematical framework was developed. Combâ€¦

- **[Selective Diabetic Retinopathy Screening with Accuracy-Weighted Deep Ensembles and Entropy-Guided Abstention](https://arxiv.org/abs/2511.05529)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05529v1 Announce Type: new 
Abstract: Diabetic retinopathy (DR), a microvascular complication of diabetes and a leading cause of preventable blindness, is projected to affect more than 130 million individuals worldwide by 2030. Early identification is essential to reduce irreversible vision loss, yet currenâ€¦

- **[Selection and Stability of Functional Connectivity Features for Classification of Brain Disorders](https://arxiv.org/abs/2511.05531)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05531v1 Announce Type: new 
Abstract: Brain disorders are an umbrella term for a group of neurological and psychiatric conditions that have a major effect on thinking, feeling, and acting. These conditions encompass a wide range of conditions. The illnesses in question pose significant difficulties not onlyâ€¦

- **[Gravity-Awareness: Deep Learning Models and LLM Simulation of Human Awareness in Altered Gravity](https://arxiv.org/abs/2511.05536)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05536v1 Announce Type: new 
Abstract: Earth's gravity has fundamentally shaped human development by guiding the brain's integration of vestibular, visual, and proprioceptive inputs into an internal model of gravity: a dynamic neural representation enabling prediction and interpretation of gravitational forcâ€¦

- **[ConnectomeBench: Can LLMs Proofread the Connectome?](https://arxiv.org/abs/2511.05542)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05542v1 Announce Type: new 
Abstract: Connectomics - the mapping of neural connections in an organism's brain - currently requires extraordinary human effort to proofread the data collected from imaging and machine-learning assisted segmentation. With the growing excitement around using AI agents to automatâ€¦

- **[Evolutionary Dynamics of Acid Resistance in Tumors: A Mathematical Model](https://arxiv.org/abs/2511.05546)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05546v1 Announce Type: new 
Abstract: Acidosis in tumors arises from reprogrammed metabolism and compromised vasculature, creating a harsh, acidic microenvironment that drives the evolutionary selection of acid-resistant cell phenotypes. A mathematical model is proposed to integrate phenotypic evolution, miâ€¦

- **[Modeling Causal Interactions Across Brain Functional Subnetworks for Population-specific Disease Analysis](https://arxiv.org/abs/2511.05548)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05548v1 Announce Type: new 
Abstract: Current neuroimaging studies on neurodegenerative diseases and psychological risk factors have been developed predominantly in non Hispanic White cohorts, with other populations markedly underrepresented. In this work, we construct directed hyper connectomes among largeâ€¦

- **[Approximating the Mathematical Structure of Psychodynamics](https://arxiv.org/abs/2511.05580)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05580v1 Announce Type: new 
Abstract: The complexity of human cognition has meant that psychology makes more use of theory and conceptual models than perhaps any other biomedical field. To enable precise quantitative study of the full breadth of phenomena in psychological and psychiatric medicine as well asâ€¦

- **[Unsupervised whole-heart function assessment](https://arxiv.org/abs/2511.05587)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05587v1 Announce Type: new 
Abstract: Motivation: CMR is the golden standard for cardiac diagnosis, and medical data annotation is time-consuming. Thus, screening techniques from unlabeled data can help streamline the cardiac diagnosis process.
  Goal: This work aims to enable cardiac function assessment frâ€¦

- **[AI-Enhanced High-Density NIRS Patch for Real-Time Brain Layer Oxygenation Monitoring in Neurological Emergencies](https://arxiv.org/abs/2511.05612)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05612v1 Announce Type: new 
Abstract: Photon scattering has traditionally limited the ability of near-infrared spectroscopy (NIRS) to extract accurate, layer-specific information from the brain. This limitation restricts its clinical utility for precise neurological monitoring. To address this, we introduceâ€¦

- **[BrainCSD: A Hierarchical Consistency-Driven MoE Foundation Model for Unified Connectome Synthesis and Multitask Brain Trait Prediction](https://arxiv.org/abs/2511.05630)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05630v1 Announce Type: new 
Abstract: Functional and structural connectivity (FC/SC) are key multimodal biomarkers for brain analysis, yet their clinical utility is hindered by costly acquisition, complex preprocessing, and frequent missing modalities. Existing foundation models either process single modaliâ€¦

- **[An epidemiological model with waning immunity and reinfection](https://arxiv.org/abs/2511.05688)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05688v1 Announce Type: new 
Abstract: Waning immunity and reinfection are critical features of many infectious diseases, but epidemiological models often fail to capture the intricate interaction between an individual's history of immunity and their current infection status; when they do, the approach is usâ€¦

- **[HuBMAP Data Portal: A Resource for Multi-Modal Spatial and Single-Cell Data of Healthy Human Tissues](https://arxiv.org/abs/2511.05708)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05708v1 Announce Type: new 
Abstract: The NIH Human BioMolecular Atlas Program (HuBMAP) Data Portal (https://portal.hubmapconsortium.org/) serves as a comprehensive repository for multi-modal spatial and single-cell data from healthy human tissues. This resource facilitates the NIH HuBMAP consortium's missiâ€¦

- **[Dynamics of menopause from deconvolution of millions of lab tests](https://arxiv.org/abs/2511.05906)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05906v1 Announce Type: new 
Abstract: Menopause reshapes female physiology, yet its full temporal footprint is obscured by uncertainty in the age of the final menstrual period (FMP). Here we analyse cross-sectional data on 300 million laboratory tests from more than a million women in two population-scale câ€¦

- **[Topologically Invariant Permutation Test](https://arxiv.org/abs/2511.06153)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.06153v1 Announce Type: new 
Abstract: Functional brain networks exhibit topological structures that reflect neural organization; however, statistical comparison of these networks is challenging for several reasons. This paper introduces a topologically invariant permutation test for detecting topological inâ€¦

- **[Geometric and statistical analysis of avian skull morphology](https://arxiv.org/abs/2511.06426)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.06426v1 Announce Type: new 
Abstract: Understanding the growth and form of shapes is one of the most fundamental problems in biology. While many prior works have analyzed the beak shapes of Darwin's finches, other cranial features are relatively less explored. In this work, we develop geometric and statistiâ€¦

- **[On the Analogy between Human Brain and LLMs: Spotting Key Neurons in Grammar Perception](https://arxiv.org/abs/2511.06519)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.06519v1 Announce Type: new 
Abstract: Artificial Neural Networks, the building blocks of AI, were inspired by the human brain's network of neurons. Over the years, these networks have evolved to replicate the complex capabilities of the brain, allowing them to handle tasks such as image and language processâ€¦

- **[Learning Biomolecular Motion: The Physics-Informed Machine Learning Paradigm](https://arxiv.org/abs/2511.06585)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.06585v1 Announce Type: new 
Abstract: The convergence of statistical learning and molecular physics is transforming our approach to modeling biomolecular systems. Physics-informed machine learning (PIML) offers a systematic framework that integrates data-driven inference with physical constraints, resultingâ€¦

- **[A Causal Formulation of Spike-Wave Duality](https://arxiv.org/abs/2511.06602)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.06602v1 Announce Type: new 
Abstract: Understanding the relationship between brain activity and behavior is a central goal of neuroscience. Despite significant advances, a fundamental dichotomy persists: neural activity manifests as both discrete spikes of individual neurons and collective waves of populatiâ€¦

- **[Emergent self-inhibition governs the landscape of stable states in complex ecosystems](https://arxiv.org/abs/2511.06697)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.06697v1 Announce Type: new 
Abstract: Species-rich ecosystems often exhibit multiple stable states with distinct species compositions. Yet, the factors determining the likelihood of each state's occurrence remain poorly understood. Here, we characterize and explain the landscape of stable states in the randâ€¦

- **[De Novo Design of SIK3 Inhibitors via Feedback-Driven Fine-Tuning of Seq2Seq-VAE](https://arxiv.org/abs/2511.06930)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.06930v1 Announce Type: new 
Abstract: Alzheimers disease (AD), a progressive neuro-degenerative disorder, currently lacks effective therapeutic strategies that can modify disease progression. Recent studies have highlighted the circadian rhythm critical role in AD pathophysiology, implicating circadian clocâ€¦

- **[A critical assessment of the role of topology on protein thermal stability](https://arxiv.org/abs/2511.07024)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.07024v1 Announce Type: new 
Abstract: For several decades, experimental and computational studies have been used to investigate the potential functional role of knots in protein structures. A property that has attracted considerable attention is thermal stability, i.e., the extent to which a protein retainsâ€¦

- **[edible polysaccharides as stabilizers and carriers for the delivery of phenolic compounds and pigments in food formulations](https://arxiv.org/abs/2511.07264)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.07264v1 Announce Type: new 
Abstract: Food polysaccharides have emerged as suitable carriers of active substances and as additives to food and nutraceutical formulations, showing potential to stabilize bioactive compounds during the storage of microencapsulate preparations, even in the gastrointestinal tracâ€¦

- **[De-Individualizing fMRI Signals via Mahalanobis Whitening and Bures Geometry](https://arxiv.org/abs/2511.07313)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.07313v1 Announce Type: new 
Abstract: Functional connectivity has been widely investigated to understand brain disease in clinical studies and imaging-based neuroscience, and analyzing changes in functional connectivity has proven to be valuable for understanding and computationally evaluating the effects oâ€¦

- **[Higher-Order Interactions in Brain Connectomics: Implicit versus Explicit Modeling Approaches](https://arxiv.org/abs/2511.07344)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.07344v1 Announce Type: new 
Abstract: The human brain is a complex system defined by multi-way, higher-order interactions invisible to traditional pairwise network models. Although a diverse array of analytical methods has been developed to address this shortcoming, the field remains fragmented, lacking a uâ€¦

- **[Bridging Accuracy and Explainability in EEG-based Graph Attention Network for Depression Detection](https://arxiv.org/abs/2511.05537)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05537v1 Announce Type: cross 
Abstract: Depression is a major cause of global mental illness and significantly influences suicide rates. Timely and accurate diagnosis is essential for effective intervention. Electroencephalography (EEG) provides a non-invasive and accessible method for examining cerebral acâ€¦

- **[Long-bone microanatomy in elephants: microstructural insights into gigantic beasts](https://arxiv.org/abs/2511.05634)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05634v1 Announce Type: cross 
Abstract: One of the greatest challenges of terrestrial locomotion is resisting gravity. The morphological adaptive features of the limb long-bones of extant elephants, the heaviest living terrestrial animals, have previously been highlighted; however, their bone microanatomy râ€¦

- **[GastroDL-Fusion: A Dual-Modal Deep Learning Framework Integrating Protein-Ligand Complexes and Gene Sequences for Gastrointestinal Disease Drug Discovery](https://arxiv.org/abs/2511.05726)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05726v1 Announce Type: cross 
Abstract: Accurate prediction of protein-ligand binding affinity plays a pivotal role in accelerating the discovery of novel drugs and vaccines, particularly for gastrointestinal (GI) diseases such as gastric ulcers, Crohn's disease, and ulcerative colitis. Traditional computatâ€¦

- **[Explainable Deep Learning-based Classification of Wolff-Parkinson-White Electrocardiographic Signals](https://arxiv.org/abs/2511.05973)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.05973v1 Announce Type: cross 
Abstract: Wolff-Parkinson-White (WPW) syndrome is a cardiac electrophysiology (EP) disorder caused by the presence of an accessory pathway (AP) that bypasses the atrioventricular node, faster ventricular activation rate, and provides a substrate for atrio-ventricular reentrantâ€¦

- **[Spatial Selection and the Multiscale Dynamics of Urban Change](https://arxiv.org/abs/2511.06165)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.06165v1 Announce Type: cross 
Abstract: Growth is a multi-layered phenomenon in human societies, composed of socioeconomic and demographic change at many different scales. Yet, standard macroeconomic indicators average over most of these processes, blurring the spatial and hierarchical heterogeneity drivingâ€¦

- **[LLM$^3$-DTI: A Large Language Model and Multi-modal data co-powered framework for Drug-Target Interaction prediction](https://arxiv.org/abs/2511.06269)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.06269v1 Announce Type: cross 
Abstract: Drug-target interaction (DTI) prediction is of great significance for drug discovery and drug repurposing. With the accumulation of a large volume of valuable data, data-driven methods have been increasingly harnessed to predict DTIs, reducing costs across various dimâ€¦

- **[Reaction Prediction via Interaction Modeling of Symmetric Difference Shingle Sets](https://arxiv.org/abs/2511.06356)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.06356v1 Announce Type: cross 
Abstract: Chemical reaction prediction remains a fundamental challenge in organic chemistry, where existing machine learning models face two critical limitations: sensitivity to input permutations (molecule/atom orderings) and inadequate modeling of substructural interactions gâ€¦

- **[Dual-Pathway Fusion of EHRs and Knowledge Graphs for Predicting Unseen Drug-Drug Interactions](https://arxiv.org/abs/2511.06662)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.06662v1 Announce Type: cross 
Abstract: Drug-drug interactions (DDIs) remain a major source of preventable harm, and many clinically important mechanisms are still unknown. Existing models either rely on pharmacologic knowledge graphs (KGs), which fail on unseen drugs, or on electronic health records (EHRs)â€¦

- **[A Diffusion Model to Shrink Proteins While Maintaining Their Function](https://arxiv.org/abs/2511.07390)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2511.07390v1 Announce Type: cross 
Abstract: Many proteins useful in modern medicine or bioengineering are challenging to make in the lab, fuse with other proteins in cells, or deliver to tissues in the body, because their sequences are too long. Shortening these sequences typically involves costly, time-consumiâ€¦

- **[tcrLM: a lightweight protein language model for predicting T cell receptor and epitope binding specificity](https://arxiv.org/abs/2406.16995)**  
  _Tue, 11 Nov 2025 00:00:00 -0500_  
  arXiv:2406.16995v3 Announce Type: replace 
Abstract: The anti-cancer immune response relies on the bindings between T-cell receptors (TCRs) and antigens, which elicits adaptive immunity to eliminate tumor cells. This ability of the immune system to respond to novel various neoantigens arises from the immense diversityâ€¦
